Literature DB >> 8929771

Autoantibodies in leprosy sera.

L S Guedes Barbosa1, B Gilbrut, Y Shoenfeld, M A Scheinberg.   

Abstract

Our objective was to assess the prevalence of autoantibodies in patients with leprosy. Forty-one cases of lepromatous leprosy were studied. For the detection of autoantibodies we used the Elisa technique using the following purified antigens in an Elisa assay: dsDNA, ssDNA, histone, mitochondria, RNA, RNP, SS-A, SS-B, Sm, Scl-70, Anca C, Anca P and the cardiolipin complex. As a "cut off" point we used values shown on previous studies to differentiate normal from elevated values. Antibodies to SS-B, mitochondria and cardiolipin were the most prevalent in our study. Antimitochondrial antibodies distinct from those seen in primary biliary cirrhosis and antiphospholipid antibodies with variable ligand activity to B2GIP are frequent in the sera of leprosy patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929771     DOI: 10.1007/bf02231680

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

Review 1.  Antiphospholipid antibodies.

Authors:  E N Harris
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

2.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  The anticardiolipin syndrome.

Authors:  G R Hughes; N N Harris; A E Gharavi
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

4.  Possible autoimmune phenomenon in leprosy.

Authors:  A M Dhople
Journal:  Jpn J Exp Med       Date:  1972-04

5.  Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.

Authors:  C D Surh; A Ahmed-Ansari; M E Gershwin
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

6.  Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis.

Authors:  N Zurgil; R Bakimer; M Kaplan; P Youinou; Y Shoenfeld
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

7.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases.

Authors:  N Zurgil; R Bakimer; H M Moutsopoulos; A G Tzioufas; P Youinou; D A Isenberg; M Scheinberg; T Kveder; B Rozman; C Luderschmidt
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

8.  A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection.

Authors:  J E Hunt; H P McNeil; G J Morgan; R M Crameri; S A Krilis
Journal:  Lupus       Date:  1992-02       Impact factor: 2.911

9.  Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy.

Authors:  B Gilburd; L Ziporen; D Zharhary; M Blank; N Zurgil; M A Scheinberg; L H Guedes; M E Gershwin; Y Shoenfeld
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

  9 in total
  10 in total

1.  Negative specificity for DSF70 in ANA positive leprosy sera.

Authors:  Sandra Lúcia Euzébio Ribeiro; Gabriel Pacifico Seabra Nunes; Henrique Euzébio Guedes de Freitas; Cristóvão Mangueira; Morton Aaron Scheinberg
Journal:  Clin Rheumatol       Date:  2019-07-05       Impact factor: 2.980

2.  Lepromatous leprosy mimicking systemic lupus erythematosus: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Authors:  Asli Karadeniz; Lindsay Lally; Cynthia Magro; Roger Levy; Doruk Erkan; Michael D Lockshin
Journal:  HSS J       Date:  2014-08-27

3.  Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvement.

Authors:  O Rojas-Espinosa; E Becerril-Villanueva; K Wek-Rodríguez; P Arce-Paredes; E Reyes-Maldonado
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.

Authors:  Maria T Ochoa; Rosane Teles; Blake E Haas; Danny Zaghi; Huiying Li; Euzenir N Sarno; Thomas H Rea; Robert L Modlin; Delphine J Lee
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

5.  The Rubino test for leprosy is a beta2-glycoprotein 1-dependent antiphospholipid reaction.

Authors:  A Panunto-Castelo; I C Almeida; J C Rosa; L J Greene; M Roque-Barreira
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

6.  Lupus and leprosy: beyond the coincidence.

Authors:  F M Ribeiro; V E Gomez; E M N Albuquerque; E M Klumb; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 7.  Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Yoh Zen; Robin Daniel Abeles; Charalambos Billinis; Albert Pares; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

8.  Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease.

Authors:  S Loizou; S Singh; E Wypkema; R A Asherson
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

9.  Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association.

Authors:  Luiz Sergio Guedes-Barbosa; Cristovão Mangueira; Morton Scheinberg
Journal:  Clin Rheumatol       Date:  2007-12-18       Impact factor: 2.980

Review 10.  Leprosy and women.

Authors:  Rashmi Sarkar; Swetalina Pradhan
Journal:  Int J Womens Dermatol       Date:  2016-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.